NCT01597388 - AZD2014 and Fulvestrant in Patients With ER+ Advanced Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 8, 2012

Primary Completion Date

August 4, 2016

Study Completion Date

September 5, 2028

Conditions

Advanced Metastatic Breast Cancer

Interventions

DRUG

AZD2014

Single dose followed by multiple dosing or twice daily dosing for 2 days folllowed by 5 days off each week, or twice daily dosing on the first and fourth day of the week

DRUG

Fulvestrant

IM monthly after loading dose

Trial Locations (5)

29605

Research Site, Greenville

34232

Research Site, Sarasota

37203

Research Site, Nashville

48201

Research Site, Detroit

73104

Research Site, Oklahoma City